About the Journal

The Haematology Oncology Research Journal (HORJ) is an international, peer-reviewed, open-access journal committed to advancing knowledge in the fields of haematology, oncology, and related biomedical sciences. HORJ provides a platform for clinicians, researchers, and healthcare professionals to publish high-quality research articles, reviews, and case studies that contribute to the understanding, diagnosis, treatment, and prevention of blood disorders and cancers.

By promoting the exchange of knowledge and collaboration across disciplines, HORJ seeks to foster innovation in clinical practice, translational medicine, and laboratory research. The journal supports global dialogue in the fight against cancer and haematological diseases, emphasizing evidence-based approaches and emerging therapies.

Aim

The aim of the Haematology Oncology Research Journal is to accelerate the dissemination of impactful discoveries and evidence-based practices that improve patient outcomes in haematology and oncology. The journal is committed to:

  • Publishing pioneering clinical, translational, and basic research in blood disorders and cancer.
  • Encouraging multidisciplinary collaboration among oncologists, haematologists, pathologists, geneticists, and biomedical scientists.
  • Providing a global platform for innovative approaches to diagnostics, therapeutics, and patient care.
  • Supporting open access to scientific knowledge for equitable healthcare advancements worldwide.

Scope

HORJ covers a broad spectrum of topics within haematology and oncology, including but not limited to:

  • Haematological Malignancies: Leukemia, lymphoma, multiple myeloma, and related disorders.
  • Solid Tumors: Breast cancer, lung cancer, colorectal cancer, prostate cancer, and rare cancers.
  • Blood Disorders: Anaemia, bleeding disorders, clotting abnormalities, sickle cell disease, and thalassemia.
  • Clinical Oncology: Chemotherapy, radiotherapy, targeted therapy, immunotherapy, and palliative care.
  • Translational and Molecular Research: Cancer genomics, biomarkers, stem cell biology, and molecular pathways.
  • Diagnostics and Imaging: Advances in laboratory diagnostics, imaging technologies, and pathology.
  • Therapeutic Innovations: Cell therapies, bone marrow transplantation, precision medicine, and novel drug development.
  • Public Health and Global Oncology: Cancer prevention, early detection, epidemiology, health disparities, and healthcare policy.

HORJ publishes original research articles, systematic reviews, meta-analyses, case reports, short communications, and commentary pieces that align with its mission to advance knowledge and practice in haematology and oncology.